In a recent research report by Maximize Market Research, the Global Market for Foot and Mouth Disease Vaccines is expected to exceed US$ 3.48 billion by the year 2027, from US$ 2.24 billion in 2020.
Increasing demand for animal products and growing livestock population, rising prevalence of FMD, increasing demand for high quality disease free meat, ongoing research & development activities, increase in R&D funding, launch of new promising products and increase in demand for cost-effective products propel the Foot and Mouth Disease Vaccines Market
The report published by Maximize, encompasses the various market dynamics, which could affect the market growth of Foot and Mouth Disease Vaccines in the region, the Value – Chain analysis, and the PORTER’s analysis for the Foot and Mouth Disease Vaccines market at a global level.
The study is consolidated on the basis of three major segments and further into sub-segments, By Vaccine Type (Conventional Vaccines, Emergency Vaccines), By Animal Type (Cattle, Sheep and goat, Pig, Others), to forecast the market size by value; also includes the analysis of past market dynamics from 2016 to 2019, considering 2020 as the base year.
Lastly, the market research report provides a regional comparison and a complete country-level analysis for the latest trends, along with the major key players (India Immunological Ltd., Merck Animal Health, Brilliant Bio Pharma Ltd., Ceva Santé Animale, Boehringer Ingelheim GmbH, Biovet Private Limited, Biovencer Healthcare Private Limited, Vetal Animal Health Products S.A, Biogenesis Bago SA, Agrovet, FGBI – Federal Centre for Animal Health, Indian Immunologicals Limited, Merial, Veterinary Serum and Vaccine Research Institute, FMD Center, Limor de Colombia) in the Foot and Mouth Disease Vaccines market, across the region.
You can browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Global Foot and Mouth Disease Vaccines Market.”
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Office no. 4,
Navale IT Zone Phase-2,
Mumbai -Bangalore bypass highway,